A detailed history of Tower Research Capital LLC (Trc) transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,222 shares of TXG stock, worth $50,392. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,222
Previous 4,786 32.68%
Holding current value
$50,392
Previous $179,000 65.36%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$19.45 - $37.37 $30,419 - $58,446
-1,564 Reduced 32.68%
3,222 $62,000
Q1 2024

May 15, 2024

BUY
$36.08 - $54.3 $59,026 - $88,834
1,636 Added 51.94%
4,786 $179,000
Q4 2023

Feb 13, 2024

BUY
$34.32 - $57.55 $15,306 - $25,667
446 Added 16.49%
3,150 $176,000
Q3 2023

Nov 14, 2023

SELL
$40.86 - $62.98 $165,809 - $255,572
-4,058 Reduced 60.01%
2,704 $111,000
Q2 2023

Aug 14, 2023

BUY
$50.96 - $58.72 $203 - $234
4 Added 0.06%
6,762 $377,000
Q1 2023

May 09, 2023

BUY
$35.33 - $55.79 $136,232 - $215,126
3,856 Added 132.87%
6,758 $377,000
Q4 2022

Feb 10, 2023

SELL
$24.4 - $41.3 $401,258 - $679,178
-16,445 Reduced 85.0%
2,902 $106,000
Q3 2022

Nov 10, 2022

BUY
$28.48 - $52.59 $55,507 - $102,497
1,949 Added 11.2%
19,347 $551,000
Q2 2022

Aug 15, 2022

BUY
$36.95 - $82.41 $359,929 - $802,755
9,741 Added 127.22%
17,398 $788,000
Q1 2022

May 12, 2022

BUY
$55.7 - $145.79 $201,634 - $527,759
3,620 Added 89.67%
7,657 $583,000
Q4 2021

Feb 14, 2022

BUY
$135.05 - $182.59 $192,041 - $259,642
1,422 Added 54.38%
4,037 $602,000
Q3 2021

Nov 15, 2021

SELL
$145.58 - $192.14 $1.7 Million - $2.24 Million
-11,658 Reduced 81.68%
2,615 $380,000
Q2 2021

Aug 16, 2021

SELL
$134.22 - $202.37 $194,887 - $293,841
-1,452 Reduced 9.23%
14,273 $2.8 Million
Q1 2021

May 17, 2021

BUY
$140.25 - $196.86 $1.71 Million - $2.4 Million
12,179 Added 343.46%
15,725 $2.85 Million
Q4 2020

Feb 16, 2021

BUY
$126.47 - $163.7 $418,742 - $542,010
3,311 Added 1408.94%
3,546 $502,000
Q3 2020

Nov 16, 2020

SELL
$87.44 - $125.0 $56,661 - $81,000
-648 Reduced 73.39%
235 $29,000
Q2 2020

Aug 13, 2020

BUY
$58.39 - $89.31 $51,558 - $78,860
883 New
883 $79,000
Q1 2020

May 15, 2020

SELL
$51.57 - $106.62 $271,412 - $561,141
-5,263 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$46.07 - $79.54 $14,327 - $24,736
311 Added 6.28%
5,263 $401,000
Q3 2019

Nov 05, 2019

BUY
$49.99 - $62.0 $247,550 - $307,024
4,952 New
4,952 $250,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.49B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.